Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 543 Clinical Trials
ID/Name Source Type
18-Month Double-Blind, Placebo-Controlled Study of Curcumin
NCT01383161 clinicaltrials.gov Clinical Trial
18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
NCT02031198 clinicaltrials.gov Clinical Trial
2-HOBA: Initial Evaluation in Humans
NCT03176940 clinicaltrials.gov Clinical Trial
2-HOBA: Multiple Dosing Study in Healthy Humans
NCT03555682 clinicaltrials.gov Clinical Trial
2-HOBA: Multiple Dosing Study in Older Adults
NCT03556319 clinicaltrials.gov Clinical Trial
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
NCT02579252 clinicaltrials.gov Clinical Trial
24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion
NCT02361242 clinicaltrials.gov Clinical Trial
3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease
NCT01374438 clinicaltrials.gov Clinical Trial
4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease
NCT01039701 clinicaltrials.gov Clinical Trial
A 12 Week Randomized, Double Blind, Placebo-Controlled Pilot Study of Davunetide (NAP, AL-108) in Predicted Tauopathies
NCT01056965 clinicaltrials.gov Clinical Trial